Mortality and Economic Impact of Recurrent Severe Hypoglycemia in T1D

This presentation explores a study on severe hypoglycemic events (SHE) in Type 1 Diabetes (T1D) patients. It covers the study's objectives, including an introduction to Zimislecel and incremental SHE assessment goals. Methodology details such as data sourcing, cohort design, and inclusion/exclusion criteria are explained. Key outcomes focus on mortality measures, healthcare resource usage, and the economic burden associated with SHE. The discussion aims to provide valuable insights into the...